Key facts
- It has raised $5.0M; the latest was Seed Round ($5.0M) in Feb 2026.
- Notable investors include South Park Commons, OneFlow Holdings.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Cent (Diagnostic Equipment)
- ·The full record, as it builds
Funding rounds
No funding rounds for Cent (Diagnostic Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cent (Diagnostic Equipment)
Developer of a preventive health screening platform designed to detect diseases early through combined imaging, biomarker analysis, and artificial intelligence. The company's platform offers full-body MRI scans, calcium scoring, dexa scans, blood and urine biomarker testing, genetic risk analysis, and doctor consultation services, enabling individuals to obtain early-detection insights and structured health reports across multiple disease risks.
- Sector
- Healthcare
- HQ
- Bangalore, India
- Founded
- 2025
- Website
- cent.health/
- Ownership
- Privately Held (backing)
Cent (Diagnostic Equipment) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cent (Diagnostic Equipment) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cent (Diagnostic Equipment) in its N-PORT filings yet. We sweep new filings monthly.